Search

everythinglearnresearchcommunity

for

Search:↓

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

A rare skin condition called linear lichen planopilaris caused itchy red bumps and hair loss on a man's face.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Isotretinoin was not effective in treating facial lichen planopilaris.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

A unique case showed a rare combination of two types of lichen planus on the face.

People with lichen planopilaris often have seborrheic dermatitis, which can delay the diagnosis of lichen planopilaris.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Hair transplants for male baldness can show inflammation and fibrosis, but more research is needed to confirm LPP presence.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.